Steroid Avoidance with Alemtuzumab Induction and Tacrolimus Monotherapy Gives Similar Outcomes to Basiliximab Induction with Tacrolimus/Mycophenolate Maintenance at Three Years

被引：0
|
作者：
Smith, M. Welberry [1 ]
Cherukuri, A. [1 ]
Newstead, C. [1 ]
Lewington, A. [1 ]
Ahmad, N. [2 ]
Menon, K. [2 ]
Pollard, S. [2 ]
Prasad, P. [3 ]
Tibble, S. [1 ]
Giddings, E. [1 ]
Baker, R. [1 ]
机构：
[1] St James Univ Hosp, Dept Renal Med & Transplantat, Leeds LS9 7TF, Yorks, England
[2] St James Univ Hosp, Dept Transplant Surg, Leeds LS9 7TF, Yorks, England
[3] St James Univ Hosp, Dept Histopathol, Leeds LS9 7TF, Yorks, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [31] Low Incidence of NODAT with Alemtuzumab Induction and Tacrolimus Monotherapy without Steroids and MMF in Renal Transplantation.
    Chan, K.
    Lawrence, C.
    Charif, R.
    McLean, A.
    Cairns, T. D. H.
    Duncan, N.
    Goodall, D.
    Palmer, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 513 - 513
  • [32] 5-Year Outcomes of a Randomized Prospective Trial of Tacrolimus Maintenance Monotherapy After Alemtuzumab Induction and Early Steroid Withdrawal in Kidney Transplantation: Rejection, HLA Antibody Formation, and Recurrent Disease.
    McLean, A.
    Chan, K.
    Roufosse, C.
    Cook, T.
    Brookes, P.
    Goodall, D.
    Willicombe, M.
    Galliford, J.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 114 - 114
  • [33] 5-Year Outcomes of a Randomized Prospective Trial of Tacrolimus Maintenance Monotherapy After Alemtuzumab Induction and Early Steroid Withdrawal in Kidney Transplantation: Rejection, HLA Antibody Formation, and Recurrent Disease.
    McLean, A.
    Chan, K.
    Roufosse, C.
    Cook, T.
    Brookes, P.
    Goodall, D.
    Willicombe, M.
    Galliford, J.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 114 - 114
  • [34] One Agent-Once a Day: 2 Year Outcomes of a Prospective Randomized Trial of Once Daily (Extended Release) Tacrolimus Maintenance Monotherapy vs Twice Daily (Standard Release) Tacrolimus After Alemtuzumab Induction & Early Steroid Cessation (TAESR Trial). Rejection and Variation in Tacrolimus Levels
    McLean, A.
    Brookes, P.
    Charif, R.
    Cook, T.
    Galliford, J.
    Goodall, D.
    Lee, J.
    Roufosse, C.
    Willicombe, M.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 536 - 536
  • [35] One Agent-Once a Day: 2 Year Outcomes of a Prospective Randomized Trial of Once Daily (Extended Release) Tacrolimus Maintenance Monotherapy vs Twice Daily (Standard Release) Tacrolimus After Alemtuzumab Induction & Early Steroid Cessation (TAESR Trial). Rejection and Variation in Tacrolimus Levels.
    McLean, A.
    Brookes, P.
    Charif, R.
    Cook, T.
    Galliford, J.
    Goodall, D.
    Lee, J.
    Roufosse, C.
    Willicombe, M.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 536 - 536
  • [36] Basiliximab Induction and Postoperative Steroid-free Immunosuppression With Tacrolimus in Pediatric Liver Transplantation: A Randomized Clinical Trial
    Dong, Chong
    Song, Zhuolun
    Sun, Chao
    Wang, Kai
    Zhang, Wei
    Chen, Jing
    Zheng, Weiping
    Yang, Yang
    Wang, Zhen
    Han, Chao
    Jiao, Lijun
    Zhang, Guofeng
    Xie, Enbo
    Gao, Wei
    Shen, Zhongyang
    TRANSPLANTATION, 2024, 108 (08) : 1769 - 1775
  • [37] Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression
    Spada, M.
    Petz, W.
    Bertani, A.
    Riva, S.
    Sonzogni, A.
    Giovannelli, M.
    Torri, E.
    Torre, G.
    Colledan, M.
    Gridelli, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (08) : 1913 - 1921
  • [38] Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: Results of a prospective randomized trial
    Boesmueller, Claudia
    Oellinger, Robert
    Sieb, Michael
    Weissenbacher, Annemarie
    Schneeberger, Stefan
    Pratschke, Johann
    Margreiter, Raimund
    ANNALS OF TRANSPLANTATION, 2012, 17 (04) : 45 - 51
  • [39] Rejection characteristics of 266 living donor kidney only transplants using alemtuzumab induction and tacrolimus monotherapy.
    Tan, Henkie P.
    Basu, Amit
    Unruh, Mark
    McCauley, Jerry
    Wu, Christine
    Shah, Nirav
    Donaldson, Joseph
    Marcos, Arnadeo
    Randhawa, Partrijeet
    Starzl, Thomas E.
    Lakkis, Fadi
    Shapiro, Ron
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 235 - 235
  • [40] Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation
    Thomas, Philip G.
    Woodside, Kenneth J.
    Lappin, Jacqueline A.
    Vaidya, Smita
    Rajaraman, Srinivasan
    Gugliuzza, Kristene K.
    TRANSPLANTATION, 2007, 83 (11) : 1509 - 1512
12345